Business
Britain goes on COVID-19 vaccine spending spree – The Australian Financial Review
The race is heating up among rich nations eager to get hold of stocks of as-yet unproven vaccines.
The US has booked 300 million of AstraZeneca’s first billion doses, and last week nailed a $US1.95 billion ($2.7 billion) deal with Pfizer for 100 million doses, with an option to secure an additional 500 million doses.
And the European Union is in talks with at least half a dozen developers, including Pfizer, Sanofi and Johnson & Johnson, but Reuters has reported this week that haggling continues over the price, payment method and potential liability costs.
Countries have a duty to protec…
-
Noosa News22 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News17 hours agoHelp to make recycling stick
-
Noosa News15 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business17 hours agoAlphabet’s stock looks like a brilliant buy right now